Mathematical modeling of allergy and specific immunotherapy: Th1-Th2-Treg interactions

Journal of Theoretical Biology

Volumn 269, Issue 1, 2011, Pages 70-78

  Groß, Fridolin ^a   Metzner, Gerhard ^a   Behn, Ulrich ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Desensitization; Nonlinear dynamics; Regulatory T cells

Indexed keywords

ALLERGEN; CYTOKINE;

ALLERGY; CELL ORGANELLE; COMPUTER SIMULATION; EQUATION; IMMUNE RESPONSE; NUMERICAL MODEL;

ACCURACY; ALLERGY; ANALYTIC METHOD; ARTICLE; CELL INTERACTION; CLINICAL PROTOCOL; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOTHERAPY; LYMPHOCYTE PROLIFERATION; MAINTENANCE THERAPY; MATHEMATICAL MODEL; NONLINEAR SYSTEM; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SIMULATION; STROBOSCOPY; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH2 CELL;

CELL COMMUNICATION; HUMANS; HYPERSENSITIVITY; IMMUNOTHERAPY; MODELS, IMMUNOLOGICAL; T-LYMPHOCYTES, REGULATORY; TH1 CELLS; TH2 CELLS;

EID: 77958532494     PISSN: 00225193     EISSN: 10958541     Source Type: Journal    
DOI: 10.1016/j.jtbi.2010.10.013     Document Type: Article

References (56)

1. Akdis C., Blesken T., Akdis M., Wüthrich B., Blaser K. Role of interleukin 10 in specific immunotherapy. J. Clin. Invest. 1998, 102(1):98-106.
2. Akdis M., Akdis C. Mechanisms of allergen-specific immunotherapy. J. Allergy Clin. Immunol. 2007, 119(4):780-789.
3. Akdis M., Verhagen J., Taylor A., Karamloo F., Karagiannidis C., Crameri R., Thunberg S., Deniz G., Valenta R., Fiebig H., et al. Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells. J. Exp. Med. 2004, 199(11):1567-1575.
4. Alexander, H., Wahl, L., 2010. Self-tolerance and autoimmunity in a regulatory T cell model. Bull. Math. Biol. 1-39, doi:. http://10.1007/s11538-010-9519-2.
5. Banchereau J., Steinman R.M. Dendritic cells and the control of immunity. Nature 1998, 392(6673):245-252.
6. Battaglia M., Gregori S., Bacchetta R., Roncarolo M.G. Tr1 cells: from discovery to their clinical application. Semin. Immunol. 2006, 18(2):120-127.
7. Behn U., Dambeck H., Metzner G. Modeling Th1-Th2 regulation, allergy and hyposensitization. Dynamical Modeling in Biotechnology 2001, 227-247. World Scientific, Singapore. F. Bagnoli, S. Ruffo (Eds.).
8. Bergmann C., Van Hemmen J., Segel L. Th1 or Th2: how an appropriate T helper response can be made. Bull. Math. Biol. 2001, 63(3):405-430.
9. Bewick S., Yang R., Zhang M. The danger is growing! A new paradigm for immune system activation and peripheral tolerance. PloS One 2009, 4(12):e8112.
10. Bousquet J., Lockey R., Malling H. Allergen immunotherapy: therapeutic vaccines for allergic diseases A WHO position paper. J. Allergy Clin. Immunol. 1998, 102(4):558-562.
11. Burroughs N.J., Miguel Paz Mendes de Oliveira B., Adrego Pinto A. Regulatory T cell adjustment of quorum growth thresholds and the control of local immune responses. J. Theor. Biol. 2006, 241(1):134-141.
12. Carneiro J., Leon K., Caramalho Í., van den Dool C., Gardner R., Oliveira V., Bergman M.L., Sepúlveda N., Paixão T., Faro J., Demengeot J. When three is not a crowd: a crossregulation model of the dynamics and repertoire selection of regulatory CD4+ T cells. Immunol. Rev. 2007, 216(1):48-68.
13. Carneiro J., Stewart J., Coutinho A., Coutinho G. The ontogeny of class-regulation of CD4+ T lymphocyte populations. Int. Immunol. 1995, 7(8):1265-1277.
14. Cella M., Engering A., Pinet V., Pieters J., Lanzavecchia A. Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells. Nature 1997, 388(6644):782-787.
15. Chan C., Lechler R., George A. Tolerance mechanisms and recent progress. Transplant 2004, vol. 36:561-569. Elsevier.
16. Couper K.N., Blount D.G., Riley E.M. IL-10: the master regulator of immunity to infection. J. Immunol. 2008, 180(9):5771-5777.
17. Cox L. Advantages and disadvantages of accelerated immunotherapy schedules. J. Allergy Clin. Immunol. 2008, 122(2):432-434.
18. Curotto de Lafaille M.A., Kutchukhidze N., Shen S., Ding Y., Yee H., Lafaille J.J. Adaptive Foxp3+ regulatory T cell-dependent and-independent control of allergic inflammation. Immunity 2008, 29(1):114-126.
19. Durham S.R., Walker S.M., Varga E.M., Jacobson M.R., O'Brien F., Noble W., Till S.J., Hamid Q.A., Nouri-Aria K.T. Long-term clinical efficacy of grass-pollen immunotherapy. New Engl. J. Med. 1999, 341(7):468-475.
20. Eftimie, R., Bramson, J.L., Earn, D.J.D., 2010. Modeling anti-tumor Th1 and Th2 immunity in the rejection of melanoma. J. Theor. Biol. 265 (3), 467-480.
21. Eich-Wanger C., Müller U.R. Bee sting allergy in beekeepers. Clin. Exp. Allergy 1998, 28(10):1292-1298.
22. Fenton A., Lamb T., Graham A.L. Optimality analysis of Th1/Th2 immune responses during microparasite-macroparasite co-infection, with epidemiological feedbacks. Parasitology 2008, 135(7):841-853.
23. Fishman M.A., Perelson A.S. Th1/Th2 cross regulation. J. Theor. Biol. 1994, 170(1):25-56.
24. Fishman M.A., Perelson A.S. Th1/Th2 differentiation and cross-regulation. Bull. Math. Biol. 1999, 61(3):403-436.
25. Fishman M.A., Segel L.A. Modeling immunotherapy for allergy. Bull. Math. Biol. 1996, 58(6):1099-1121.
26. Fouchet D., Regoes R. A population dynamics analysis of the interaction between adaptive regulatory T cells and antigen presenting cells. PLoS One 2008, 3(5):e2306.
27. Galli S., Tsai M., Piliponsky A. The development of allergic inflammation. Nature 2008, 454(7203):445-454.
28. Huang S., Eichler G., Bar-Yam Y., Ingber D.E. Cell fates as high-dimensional attractor states of a complex gene regulatory network. Phys. Rev. Lett. 2005, 94(12):128701.1-128701.4.
29. Jonuleit H., Schmitt E., Schuler G., Knop J., Enk A. Induction of interleukin 10-producing: nonproliferating CD4+ T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J. Exp. Med. 2000, 192(9):1213-1222.
30. Kim P.S., Lee P.P., Levy D. Emergent group dynamics governed by regulatory cells produce a robust primary T cell response. Bull. Math. Biol. 2010, 72(3):611-644.
31. Lanzavecchia A., Sallusto F. Regulation of T cell immunity by dendritic cells. Cell 2001, 106(3):263-266.
32. León K., Faro J., Lage A., Carneiro J. Inverse correlation between the incidences of autoimmune disease and infection predicted by a model of T cell mediated tolerance. J. Autoimmun. 2004, 22(1):31-42.
33. León K., Perez R., Lage A., Jorge A. Modelling T-cell-mediated suppression dependent on interactions in multicellular conjugates. J. Theor. Biol. 2000, 207(2):231-254.
34. Louzoun Y., Atlan H., Cohen I.R. Modeling the influence of TH1-and TH2-type cells in autoimmune diseases. J. Autoimmun. 2001, 17(4):311-321.
35. Mamessier E., Birnbaum J., Dupuy P., Vervloet D., Magnan A. Ultra-rush venom immunotherapy induces differential T cell activation and regulatory patterns according to the severity of allergy. Clin. Exp. Allergy 2006, 36(6):704-713.
36. Mosmann T.R., Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol. Today 1996, 17(3):138-146.
37. Murphy K.M., Travers P., Walport M. Janeway's Immunobiology 2007, Garland Science Publishing, New York. seventh ed.
38. Oboki K., Ohno T., Saito H., Nakae S. Th17 and allergy. Allergol. Int. 2008, 57(2):121-134.
39. Peng Z., Simons F.E.R. Mosquito allergy: immune mechanisms and recombinant salivary allergens. Int. Arch. Allergy Immunol. 2004, 133(2):198-209.
40. Richter J., Metzner G., Behn U. Mathematical modelling of venom immunotherapy. J. Theor. Med. 2002, 4(2):119-132.
41. Romagnani S. The Th1/Th2 paradigm. Immunol. Today 1997, 18(6):263-266.
42. Ruedl C., Bachmann M.F., Kopf M. The antigen dose determines T helper subset development by regulation of CD40 ligand. Eur. J. Immunol. 2000, 30(7):2056-2064.
43. Ruëff F., Przybilla B., Fuchs T., Gall H., Rakoski J., Stolz W., Vieluf D. Diagnose und Therapie der Bienen-und Wespengiftallergie. Allergol. J. 2000, 9:458-472.
44. Sakaguchi S. Regulatory T cells key controllers of immunologic self-tolerance. Cell 2000, 101(5):455-458.
45. Sakaguchi S. Naturally arising Foxp3-expressing CD25+ CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat. Immunol. 2005, 6(4):345-352.
46. Schmidt-Weber C.B., Akdis M., Akdis C.A. TH17 cells in the big picture of immunology. J. Allergy Clin. Immunol. 2007, 120(2):247-254.
47. Secrist H., DeKruyff R., Umetsu D. Interleukin 4 production by CD4+ T cells from allergic individuals is modulated by antigen concentration and antigen-presenting cell type. J. Exp. Med. 1995, 181(3):1081-1089.
48. Shevach E.M. Mechanisms of foxp3+ T regulatory cell-mediated suppression. Immunity 2009, 30(5):636-645.
49. Taylor A., Verhagen J., Blaser K., Akdis M., Akdis C.A. Mechanisms of immune suppression by interleukin-10 and transforming growth factor-Β: the role of T regulatory cells. Immunology 2006, 117(4):433-442.
50. Van Den Ham H., De Boer R. From the two-dimensional Th1 and Th2 phenotypes to high-dimensional models for gene regulation. Int. Immunol. 2008, 20(10):1269-1277.
51. Vogel R., Behn U. Th1-Th2 regulation and allergy: bifurcation analysis of the non-autonomous system. Mathematical Modeling of Biological Systems 2007, 155-157. Birkhäuser, Boston. A. Deutsch (Ed.).
52. Wei G., Wei L., Zhu J., Zang C., Hu-Li J., Yao Z., Cui K., Kanno Y., Roh T.Y., Watford W.T., et al. Global mapping of H3K4me3 and H3K27me3 reveals specificity and plasticity in lineage fate determination of differentiating CD4+ T cells. Immunity 2009, 30(1):155-167.
53. Wills-Karp M., Santeliz J., Karp C.L. The germless theory of allergic disease: revisiting the hygiene hypothesis. Nat. Rev. Immunol. 2001, 1(1):69-75.
54. Yates A., Bergmann C., Leo Van Hemmen J., Stark J., Callard R. Cytokine-modulated regulation of helper T cell populations. J. Theor. Biol. 2000, 206(4):539-560.
55. Yazdanbakhsh M., Kremsner P.G., van Ree R. Allergy, parasites, and the hygiene hypothesis. Science 2002, 296(5567):490-494.
56. Zhu J., Paul W.E. Heterogeneity plasticity of T helper cells. Cell Res. 2009, 20:4-12.